Stifel Financial’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.03M | Buy |
|
|||||
|
2025
Q1 | $1.87M | Buy |
|
|||||
|
2024
Q4 | $1.8M | Buy |
|
|||||
|
2024
Q3 | $1.6M | Buy |
|
|||||
|
2024
Q2 | $1.15M | Buy |
|
|||||
|
2024
Q1 | $582K | Buy |
|
|||||
|
2023
Q4 | $513K | Sell |
|
|||||
|
2023
Q3 | $442K | Sell |
|
|||||
|
2023
Q2 | $548K | Buy |
|
|||||
|
2023
Q1 | $324K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $734K | Sell |
|
|||||
|
2020
Q3 | $755K | Buy |
|
|||||
|
2020
Q2 | $812K | Buy |
|
|||||
|
2020
Q1 | $318K | Sell |
|
|||||
|
2019
Q4 | $7.73M | Sell |
|
|||||
|
2019
Q3 | $7.81M | Sell |
|
|||||
|
2019
Q2 | $12.6M | Buy |
|
|||||
|
2019
Q1 | $12.7M | Sell |
|
|||||
|
2018
Q4 | $13.8M | Buy |
|
|||||
|
2018
Q3 | $23.2M | Sell |
|
|||||
|
2018
Q2 | $24.9M | Buy |
|
|||||
|
2018
Q1 | $19.5M | Buy |
|
|||||
|
2017
Q4 | $15.4M | Buy |
|
|||||
|
2017
Q3 | $14.8M | Buy |
|
|||||
|
2017
Q2 | $857K | Buy |
|
|||||
|
2017
Q1 | $736K | Buy |
|
|||||
|
2016
Q4 | $666K | Buy |
|
|||||
|
2016
Q3 | $427K | Buy |
|
|||||
|
2016
Q2 | $259K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $360K | Buy |
|